Apr. 14 at 2:15 PM
$RXO 🧬 NASDAQ:МYNZ — Biotech Quiet Play with High Potential
Маіnz Віоmеd isn’t just another name in biotech.
It’s focused on mRNA, diagnostics, and early cancer detection — all at the core of the next-gen healthcare wave.
While others chase noise, this setup is quietly building.
No PR yet. No major grants. No hype. But the structure is in place.
📌 Microfloat. U.S.-based. Strong alignment with key biotech funding themes.
This could be one of those tickers that moves quickly once noticed.
Low float names tend to do that — especially when narrative + tech align.
📊 R/R here remains compelling.
I’m holding with conviction. Monitoring closely.
DYOR.
